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Protein ubiquitination is an evolutionarily conserved and functionally diverse post-translational modification achieved
through the sequential action of E1-activating enzymes, E2-conjugating enzymes and E3 ligases. A summary of validated
ubiquitination substrates have been presented and a prediction of new substrates have been conducted in yeast. However,
a systematic summary of human ubiquitination substrates containing experimental evidence and the enzymatic cascade of
each substrate is not available. In the present study, hUbiquitome web resource is introduced, a public resource for the
retrieval of experimentally verified human ubiquitination enzymes and substrates. hUbiquitome is the first comprehensive
database of human ubiquitination cascades. Currently, hUbiquitome has in its repertoire curated data comprising 1 E1
enzyme, 12 E2 enzymes, 138 E3 ligases or complexes, 279 different substrate proteins and 17 deubiquitination enzyme
terms. The biological functions of substrates from different kinds of E3s were analyzed using the collected data.
The findings show that substrates ubiquitinated by RING (Really Interesting New Gene) E3s are enriched most in
apoptosis-related processes, whereas substrates ubiquitinated by other E3s are enriched in gene expression-associated
processes. An analysis of the data demonstrates the biological process preferences of the different kinds of E3s.
hUbiquitome is the first database to systematically collect experimentally validated ubiquitinated proteins and related
ubiquitination cascade enzymes which might be helpful in the field of ubiquitination-modification research.
Database URL: http://202.38.126.151/hmdd/hubi/
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Introduction
Ubiquitination is an important type of post-translational
modification in which an isopeptide bond is formed
between the C-terminus of ubiquitin and a lysine residue
from either a substrate or another ubiquitin molecule (1).
In addition to its original role in protein degradation (2),
ubiquitination regulates other cellular processes, including
transcription, cell cycle, DNA repair, apoptosis and receptor
endocytosis (3). Thus, aberrations of ubiquitin–proteasome
system function in all the above-mentioned processes
have been implicated in the pathogenesis of human
diseases, ranging from inflammatory, neurodegenerative
muscle-wasting, to various forms of malignancies (4, 5).
A few resources of ubiquitination data are available.
Ubiprot is the first database on ubiquitination (6), which
focuses on the properties of ubiquitinated proteins per se,
with data from different species combined. The data in
Ubiprot are mainly sourced from several high-throughput
studies, and do not include information of ubiquitination
cascade enzymes. The other ubiquitination database is a
yeast database [Saccharomyces cerevisiae Ubiquitination
Database (SCUD)] focusing on ubiquitination cascades (7).
SCUD has collected almost all known enzymes involved in
the ubiquitination process of yeast and has grouped them
into reasonable classes. E3Miner is a text-mining tool for
literature search (8), and appears to replace labor-intense
manual curation with machine learning approach.
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mation, obtaining high accuracy in the text-mining method
is difficult. Ubiquitination is a conserved biological process
from yeasts to humans (1, 9–12). Understanding of the
human ubiquitination system has gradually become clearer
as more enzymes and ubiquitinated proteins have been
discovered (13–15). However, no database demonstrating
those of the human ubiquitination system exists.
hUbiquitome is the first and largest searchable collec-
tion of human ubiquitination proteins and cascades.
hUbiquitome was constructed based on published papers
in PubMed, and all the ubiquitination proteins and
cascades were experimentally validated. hUbiquitome pro-
vides a user-friendly interface through which information
can be easily retrieved, including E1, E2 and E3 substrates,
deubiquitination enzymes (DUBs) and the relationship
among these elements. Ubiquitin lysine sites or sequences
are provided if they were identified in the reference
papers. If some E3 functions are in the form of complexes,
a complex name would be provided. hUbiquitome aims
to provide as many precise information as confirmed by
experiments in the ubiquitination cascades.
Database construction
The ubiquitination cascade data documented in the current
version, hUbiquitome 1.1.1, were collected manually
by searching the PubMed database for primary research
articles published or e-published up to the time of the
present study with a list of keywords (e1 ubiquitin OR
e2 ubiquitin-conjugating enzyme OR e3 ubiquitin ligases
Limits: Humans). Full articles and supplementary data
were examined. When appropriate, references were
checked for additional materials. Studies that described
experimentally identified relationships between E2 and E3
and E3 and Substrate were included. Only papers showing
adequate experimental evidence of substrate ubiquitina-
tion by identified E3s were selected. Experimental evidence
includes in vitro reaction of E3 and substrate, immunoblot
with ubiquitin antibody, autoradiogram of isotope-labeled
ubiquitin, tag-labeled ubiquitin detection, substrate deg-
radation by proteome, substrate stability detection and
so on. Additional information, such as E3 complex compo-
nents and ubiquitinated sites and sequences, are important
features of hUbiquitome.
Another part of the ubiquitination system is the deubi-
quitination process (16–19). DUBs are involved in multiple
cellular processes similar to ubiquitinating enzymes
(UBs). However, studies on DUBs lag behind that of UBs.
Seventeen terms of DUBs with identified substrates were
collected and added after E3-substrate cascade terms.
hUbiquitome 1.1.1 currently contains 1 E1 enzyme, 12 E2
enzymes, 138 E3 ligases or E3 ligases complexes, 279 differ-
ent substrate proteins and 17 DUB terms. All the proteins
and the related papers in the website are hyperlinked to
UniProt and PubMed.
Database description and utility
Search: hUbiquitome can be used to search for an enzyme
or substrate using the UniprotKB protein accession number
or the UniprotKB protein entry name. For example, input
’Mdm2’ inside the searchbox and search. A list of cascaded
contexts for Mdm2 appears (Figure 1). E1 is common to all
the cascades, so it is omitted. Papers reporting E3-substrates
reactions do not always inculde E2 information. To be
precise, only E2 information in the cascades reported in
previous papers are shown. However, users can deduce
that the same E2 could be used with other E3-substrates
reactions that share the same E3. For example, a paper
(PMID:18784257) reported that Mdm2 ubiquitinate UT2
uses UB2D1 as E2. Thus, UB2D1 might also be used as E2
in Mdm2-mediated ubiquitination of other substrates,
such as RUNX3, PDE4D and AQP2. In some cases, E3 func-
tions in the form of a complex. For example, ku70 and
Mdm2 function together to ubiquitinate CCNE1. A complex
name is given if E3 functions as a complex. Some
experiments identified the ubiquitinated lysine sites and
sequence motifs, such as Mdm2 ubiquitinate RUNX3 at
lysines 94 and 148. The experimentally identified ubiquiti-
nated lysine sites and sequence motifs are given as
soon as they are available. The experimental evidence
(mass spectrometry, mutation or both) identifying the
ubiquitinated lysine sites are also included. Although the
number of DUBs is small than that of E3s, we include them
in the cascades, for example, UBP7 have been reported to
be a DUB for DAXX in a paper (PMID: 20153724). MDM2
and UBP7 arranged in one row has the only meaning of
sharing the same substrates. The PubMed ID is hyperlinked
to its source page at NCBI, and each protein is ultimately
hyperlinked to major biological databases like Uniprot
and Entrez Gene.
Blast: the hUbiquitome Blast reports lysine sites in
submitted sequences that match with ubiquitinated lysine
sites in the hUbiquitome database. Thirty-five unique lysine
sites were found to be ubiquitinated by known E3s
(excluding those identified by mass spectrometry without
E3 information). The hUbiquitome Blast is useful for retriev-
ing possible ubiquitinated lysine sites of interesting pro-
teins. However, Blast does not give meaningful significant
values. Thus, the biological context of the Blast results
should be evaluated by the user.
Submit and Download: Users can submit their own pro-
teins or even entire ubiquination cascades to hUbiquitome.
Contributors just need to fill out the Excel form provided at
the Submission Page and then send it back to the database
administrator.
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download as tab-delimited text files without password
protection for academic users.
Functional analysis of E3 substrates: E3 can be divided
into two main classes (RING: Really Interesting New Gene
and HECT: homologous to E6-AP C-Terminus E3) according
to the domain structure they contain (13, 15). Other kinds
of E3s contain few numbers, such as U-box and PHD E3s
(20, 21). Whether different E3 classes prefer to catalyze
functionally different substrates has never been reported.
In this article, the biological functions of substrates cata-
lyzed by RING or HECT and other E3s are analyzed using
the online DAVID tool (22). RING substrates (RING) or HECT
and other substrates (HECT) are submitted to the DAVID
website with the background of the whole human prote-
ome. The functional annotation tool, gene ontology
biological process (GOTERM_BP), was selected to analyze
the functional enrichment of the two kinds of substrates
under default parameters. The enrichment was defined
by Benjamini-adjusted P-value designed to control false
discovery rates. From the enriched terms in both the RING
and HECT group results, nine terms were selected according
to the different enrichment and biological meanings
in the two groups. Detailed information can be found
in supplement materials. The findings show that
apoptosis-associated processes are enriched in RING E3s
(Figure 2A), whereas gene transcription regulation-
associated processes are enriched in HECT and in other
E3s (Figure 2B). This result indicates that different classes
of E3s may prefer different biological processes.
Database implementation: hUbiquitome consists of a
relational Sqlite (http://www.sqlite.org/) database and a
JqueryUI (http://jquery.com/web interface), constructed
in Python (http://www.python.org/) with Django (http://
www.djangoproject.com/) and run via an Apache server
(http://www.apache.org/).
Discussion and future direction
hUbiquitome, a database that focuses on the human
ubiquitination system, collects exact ubiquitination infor-
mation which have been experimentally validated. For
every ubiquitinated substrate, hUbiquitome provides the
other ubiquitination cascades information in one row
which includes E2, E3, ubiquitinated sites and sequences
if possible. Researchers can search for individual terms
and blast peptide sequences. They can also download the
full datasheet. Based on the collection, the biological
process preferences of RING E3s and other E3s are found,
Figure 1. General view using ‘Mdm2’ as an example.
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of E3s.
hUbiquitome was designed to cover all experimentally
validated ubiquitination associated proteins (enzymes and
substrates) and cascades in humans. More ubiquitinated
proteins will soon be discovered, although the current
version of hUbiquitome includes hundreds of them.
These newly demonstrated ubiquitinated proteins will be
added to hUbiquitome when the database is updated.
hUbiquitome does not collect ubiquitinated proteins
without E3 information produced by large-scale mass
spectrometry methods (23–25).
Researchers may benefit from hUbiquitome in three
ways. First, scholars can search for interesting proteins to
find their ubiquitination cascades. Some of these proteins
are even hyperlinked to the original papers to provide
further information. Second, based on the characteristics
of ubiquitinated peptide sequences, the BLAST function
provides researchers a tool to estimate possible ubiquitina-
tions of unknown peptides. Third, using the entire data
which can be freely downloaded from the website,
researchers can conduct further analysis. For example, the
functional preference of two classes of E3s can be analyzed.
Other interesting analyses, such as E2 and E3 substrate
network construction, are expected.
Supplementary Data
Supplementary data are available at Database online.
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